Shire to Acquire Movetis and Expand its Gastrointestinal Portfolio

By Heather Cartwright

Pharma Deals Review: Vol 2010 Issue 7 (Table of Contents)

Published: 8 Sep-2010

DOI: 10.3833/pdr.v2010.i7.1365     ISSN: 1756-7874

Section: Mergers & Acquisitions



Shire has made a conditional offer for the Belgian speciality gastrointestinal (GI) company Movetis valued at US$565 M (€428 M)...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details